Pregled bibliografske jedinice broj: 1248369
Genetic diagnosis; limb-girdle weakness; neuromuscular disease; next-generation sequencing; targeted exome analysisweakness
genetic diagnosis; limb-girdle weakness; neuromuscular disease; next-generation sequencing; targeted exome analysisweakness // Genetics in Medicine, 22 (2020), 9; 1478-1488 doi:10.1038/s41436-020-0840-3 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1248369 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Genetic diagnosis; limb-girdle weakness;
neuromuscular disease; next-generation sequencing;
targeted exome analysisweakness
(Genetic diagnosis; limb-girdle weakness;
neuromuscular disease; next-generation sequencing;
targeted exome analysis)
Autori
Töpf, Ana ; Johnson, Katherine ; Bates, Adam ; Phillips, Lauren ; Chao, Katherine R. ; England, Eleina M. ; Laricchia, Kristen M. ; Mullen, Thomas ; Valkanas, Elise ; Xu, Liwen ; Bertoli, Marta ; Blain, Alison ; Casasús, Ana B. ; Duff, Jennifer ; Mroczek, Magdalena ; Specht, Sabine ; Lek, Monkol ; Ensini, Monica ; MacArthur, Daniel G. ; Akay, Ela ; Alonso-Pérez, Jorge ; Baets, Jonathan ; Barisic, Nina ; Bastian, Alexandra ; Borell, Sabine ; Chamova, Teodora ; Claeys, Kristl ; Colomer, Jaume ; Coppens, Sandra ; Deconinck, Nicolas ; de Ridder, Willem ; Díaz-Manera, Jordi ; Domínguez-González, Cristina ; Duncan, Alexis ; Durmus, Hacer ; Fahmy, Nagia A. ; Farrugia, Maria Elena ; Fernández-Torrón, Roberto ; Gonzalez- Quereda, Lidia ; Haberlova, Jana ; von der Hagen, Maja ; Hahn, Andreas ; Jakovčević, Antonia ; Jerico Pascual, Ivonne ; Kapetanovic, Solange ; Kenina, Viktorija ; Kirschner, Janbernd ; Klein, Andrea ; Kölbel, Heike ; Kostera-Pruszczyk, Anna ; Kulshrestha, Richa ; Lähdetie, Jaana ; Layegh, Mahsa ; Longman, Cheryl ; López de Munain, Adolfo ; Loscher, Wolfgang ; Lusakowska, Anna ; Maddison, Paul ; Magot, Armelle ; Majumdar, Anirban ; Martí, Pilar ; Martínez Arroyo, Amaia ; Mazanec, Radim ; Mercier, Sandra ; Mongini, Tiziana ; Muelas, Nuria ; Nascimento, Andrés ; Nafissi, Shahriar ; Omidi, Shirin ; Ortez, Carlos ; Paquay, Stéphanie ; Pereon, Yann ; Perić, Stojan ; Ponzalino, Valentina ; Rakočević Stojanović, Vidosava ; Remiche, Gauthier ; Rodríguez Sainz, Aida ; Rudnik, Sabine ; Sanchez Albisua, Iciar ; Santos, Manuela ; Schara, Ulrike ; Shatillo, Andriy ; Sertić, Jadranka ; Stephani, Ulrich ; Strang- Karlsson, Sonja ; Sznajer, Yves ; Tanev, Ani ; Tournev, Ivailo ; Van den Bergh, Peter ; Van Parijs, Vinciane ; Vílchez, Juan ; Vill, Katharina ; Vissing, John ; Wallgren-Pettersson, Carina ; Wanschitz, Julia ; Willis, Tracey ; Witting, Nanna ; Zulaica, Miren ; Straub, Volker
Izvornik
Genetics in Medicine (1098-3600) 22
(2020), 9;
1478-1488
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
genetic diagnosis ; limb-girdle weakness ; neuromuscular disease ; next-generation sequencing ; targeted exome analysis
(genetic diagnosis ; limb-girdle weakness ; neuromuscular disease ; next-generation sequencing ; targeted exome analysis.)
Sažetak
Abstract Purpose: Several hundred genetic muscle diseases have been described, all of which are rare. Their clinical and genetic heterogeneity means that a genetic diagnosis is challenging. We established an international consortium, MYO-SEQ, to aid the work-ups of muscle disease patients and to better understand disease etiology. Methods: Exome sequencing was applied to 1001 undiagnosed patients recruited from more than 40 neuromuscular disease referral centers ; standardized phenotypic information was collected for each patient. Exomes were examined for variants in 429 genes associated with muscle conditions. Results: We identified suspected pathogenic variants in 52% of patients across 87 genes. We detected 401 novel variants, 116 of which were recurrent. Variants in CAPN3, DYSF, ANO5, DMD, RYR1, TTN, COL6A2, and SGCA collectively accounted for over half of the solved cases ; while variants in newer disease genes, such as BVES and POGLUT1, were also found. The remaining well-characterized unsolved patients (48%) need further investigation. Conclusion: Using our unique infrastructure, we developed a pathway to expedite muscle disease diagnoses. Our data suggest that exome sequencing should be used for pathogenic variant detection in patients with suspected genetic muscle diseases, focusing first on the most common disease genes described here, and subsequently in rarer and newly characterized disease genes. .
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE